By 2020, Chouinard’s discomfort with his ownership of the lucrative outdoor apparel brand was ramping up. While Patagonia has ...
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
9h
Zacks Investment Research on MSNIs A Recession Coming in 2025? Where to Invest Now(1:00) - Are We Heading Towards A Recession?(7:10) - What Can We Expect From The Fed The Next Few Months?(12:30) - How Should You Position Your Portfolio Right Now?(17:40) - Top Stocks To Keep On Your ...
With Roche's latest deal, a new contender enters the obesity space, which could threaten NVO and LLY's dominance in the ...
12h
Zacks Investment Research on MSNPharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline UpdateNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...
After the surprising election, in which the social liberal party Demokraatit became the largest party, it is time for government negotiations in Greenland.And it will take time, is the general ...
Norwegian Airlines will open a new route between Billund and London Gatwick, according to Danish media outlet TV2. The Norwegian low-cost airline will also expand its routes between Billund and ...
The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results